Loading...
Loading...
Application UK00910161677 · Dead

| Application Number | UK00910161677 |
| Status | Dead |
| Owner | Veracyte, Inc. |
| Filed | 2011-07-29 |
| Registered | 2011-12-29 |
| Renewal Due | 2021-07-29 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
UK00910161677 has a current status of Dead.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Kits for in vitro diagnostic testing; diagnostic preparations, reagents and assays for clinical or medical laboratory use; reagents for medical and/or veterinary testing purposes; products for medical or diagnostic purposes and use in medical research, and clinical or diagnostic applications; kits containing any of the aforesaid goods, for conducting medical and diagnosis tests.
Scientific research and development services in the fields of oncology, the treatment of cancer and cancer diagnostics; pharmaceutical research in the fields of pharmaceutical preparations used in the diagnosis and treatment of cancer; drug and pharmaceutical discovery; scientific research and development services in the field of oncology and the treatment and diagnosis of cancer and immune diseases; development of pharmaceuticals, biopharmaceutical preparations, vaccines, immunotherapy agents and biologics for others; medical and pharmaceutical research services; creation, updating and hosting of a website providing information in the field of oncology and the diagnosis and treatment of cancer; technical help and support services provided by telephone or electronic mail and relating to diagnostic testing; information and advisory services relating to the aforesaid provided online over the internet or extranets.
Medical diagnostic testing services; information and advisory services relating to cancer diagnostics, oncology, and pharmaceuticals, including such services provided on-line from a computer network or the Internet; testing for diagnostic or treatment purposes; medical services, namely treatment of human diseases and disorders; medical consulting services; human medical and prognostic testing services; providing a database in the field of human diseases, and adapted for the inputting and collection of data and information all for treatment and diagnostic purposes; providing medical information; medical diagnostic, theranostic, prognostic and analysis services; medical diagnostic testing, monitoring and reporting services; medical services, namely, analysis of individualized patient data to aid physicians in determining diagnostic, therapeutic and prognostic objectives for patients; providing a centralized database in the field of molecular diagnostics to allow oncologists to acquire and share molecular tumour profiling information and clinical outcomes within a collaborative, secured environment, all for treatment and diagnostic purposes; information and advisory services relating to the aforesaid provided online over the internet or extranets.
This figurative mark is indexed under the following Vienna categories by the UK IPO:
This device mark (application number UK00910161677) is a dead trademark on the UK IPO register, filed by Veracyte, Inc. on 29 July 2011, with registration granted on 29 December 2011. It is due to expire on 29 July 2021.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services).
The trademark is represented by Finnegan Europe LLP.
No — the UK IPO records the status of UK trademark UK00910161677 as dead.
UK trademark UK00910161677 is recorded in Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 5: Kits for in vitro diagnostic testing; diagnostic preparations, reagents and assays for clinical or medical laboratory use; reagents for medical and/or veterinary testing purposes; products for medical or diagnostic purposes and use in medical research, and clinical or diagnostic applications; kits containin…
UK trademark UK00910161677 was filed at the UK IPO on 29 July 2011 and registered on 29 December 2011.
UK trademark UK00910161677 is currently recorded as valid until 29 July 2021, at which point it will need to be renewed with the UK IPO to remain in force.
Finnegan Europe LLP is listed as the attorney / representative of record for UK trademark UK00910161677 on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.